Stimulation of murine lymphocytes (NK cells and T cells) by human recombinant interleukin-2 (IL-2)

J. E. Talmadge, M. E. Schneider, A. K. Meeker, J. Adams

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Efforts to define the activities of IL-2 have been limited to crude preparations containing mixtures of lymphokines or partially purified materials. Recombinant DNA technology has made large amounts of purified lymphokines available, including recombinant human IL-2 which was provided for these studies by Dr. Seth Rudnick of Biogen. This material contains 8.5 x 105 U of IL-2/mg protein with a single major band on SDS gels. We report significant in vitro stimulation of murine NK cell activity by IL-2 at >10 U/ml. In addition, the IL-2 supported the growth of murine IL-2-dependent cell lines, enhanced the blastogenesis of murine spleen cells, increased an allogeneic mixed lymphocyte response and enhanced the generation of cytotoxic cells during mixed lymphocyte-tumor cultures. These IL-2 activities were dose dependent and sensitive to freeze thawing. The intravenous injection of IL-2 does not activate splenic or peritoneal NK cells of mice whereas the intraperitoneal injection of IL-2 preferentially activates peritoneal NK cells. The availability of human recombinant IL-2 and its capacity to stimulate mouse effector cells in vitro and in vivo will allow the preclinical assessment of the immunomodulatory and therapeutic potential of IL-2.

Original languageEnglish (US)
Pages (from-to)no. 3215
JournalFederation Proceedings
Volume43
Issue number7
StatePublished - Jan 1 1984

Fingerprint

Lymphocyte Activation
Natural Killer Cells
Interleukin-2
T-Lymphocytes
Lymphokines
Lymphocytes
Recombinant DNA
Intraperitoneal Injections
Intravenous Injections
Spleen
Gels
Technology
Cell Line

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stimulation of murine lymphocytes (NK cells and T cells) by human recombinant interleukin-2 (IL-2). / Talmadge, J. E.; Schneider, M. E.; Meeker, A. K.; Adams, J.

In: Federation Proceedings, Vol. 43, No. 7, 01.01.1984, p. no. 3215.

Research output: Contribution to journalArticle

Talmadge, J. E. ; Schneider, M. E. ; Meeker, A. K. ; Adams, J. / Stimulation of murine lymphocytes (NK cells and T cells) by human recombinant interleukin-2 (IL-2). In: Federation Proceedings. 1984 ; Vol. 43, No. 7. pp. no. 3215.
@article{b8c20fbc859a479497cdc5d5abae0823,
title = "Stimulation of murine lymphocytes (NK cells and T cells) by human recombinant interleukin-2 (IL-2)",
abstract = "Efforts to define the activities of IL-2 have been limited to crude preparations containing mixtures of lymphokines or partially purified materials. Recombinant DNA technology has made large amounts of purified lymphokines available, including recombinant human IL-2 which was provided for these studies by Dr. Seth Rudnick of Biogen. This material contains 8.5 x 105 U of IL-2/mg protein with a single major band on SDS gels. We report significant in vitro stimulation of murine NK cell activity by IL-2 at >10 U/ml. In addition, the IL-2 supported the growth of murine IL-2-dependent cell lines, enhanced the blastogenesis of murine spleen cells, increased an allogeneic mixed lymphocyte response and enhanced the generation of cytotoxic cells during mixed lymphocyte-tumor cultures. These IL-2 activities were dose dependent and sensitive to freeze thawing. The intravenous injection of IL-2 does not activate splenic or peritoneal NK cells of mice whereas the intraperitoneal injection of IL-2 preferentially activates peritoneal NK cells. The availability of human recombinant IL-2 and its capacity to stimulate mouse effector cells in vitro and in vivo will allow the preclinical assessment of the immunomodulatory and therapeutic potential of IL-2.",
author = "Talmadge, {J. E.} and Schneider, {M. E.} and Meeker, {A. K.} and J. Adams",
year = "1984",
month = "1",
day = "1",
language = "English (US)",
volume = "43",
pages = "no. 3215",
journal = "Federation Proceedings",
issn = "0014-9446",
number = "7",

}

TY - JOUR

T1 - Stimulation of murine lymphocytes (NK cells and T cells) by human recombinant interleukin-2 (IL-2)

AU - Talmadge, J. E.

AU - Schneider, M. E.

AU - Meeker, A. K.

AU - Adams, J.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - Efforts to define the activities of IL-2 have been limited to crude preparations containing mixtures of lymphokines or partially purified materials. Recombinant DNA technology has made large amounts of purified lymphokines available, including recombinant human IL-2 which was provided for these studies by Dr. Seth Rudnick of Biogen. This material contains 8.5 x 105 U of IL-2/mg protein with a single major band on SDS gels. We report significant in vitro stimulation of murine NK cell activity by IL-2 at >10 U/ml. In addition, the IL-2 supported the growth of murine IL-2-dependent cell lines, enhanced the blastogenesis of murine spleen cells, increased an allogeneic mixed lymphocyte response and enhanced the generation of cytotoxic cells during mixed lymphocyte-tumor cultures. These IL-2 activities were dose dependent and sensitive to freeze thawing. The intravenous injection of IL-2 does not activate splenic or peritoneal NK cells of mice whereas the intraperitoneal injection of IL-2 preferentially activates peritoneal NK cells. The availability of human recombinant IL-2 and its capacity to stimulate mouse effector cells in vitro and in vivo will allow the preclinical assessment of the immunomodulatory and therapeutic potential of IL-2.

AB - Efforts to define the activities of IL-2 have been limited to crude preparations containing mixtures of lymphokines or partially purified materials. Recombinant DNA technology has made large amounts of purified lymphokines available, including recombinant human IL-2 which was provided for these studies by Dr. Seth Rudnick of Biogen. This material contains 8.5 x 105 U of IL-2/mg protein with a single major band on SDS gels. We report significant in vitro stimulation of murine NK cell activity by IL-2 at >10 U/ml. In addition, the IL-2 supported the growth of murine IL-2-dependent cell lines, enhanced the blastogenesis of murine spleen cells, increased an allogeneic mixed lymphocyte response and enhanced the generation of cytotoxic cells during mixed lymphocyte-tumor cultures. These IL-2 activities were dose dependent and sensitive to freeze thawing. The intravenous injection of IL-2 does not activate splenic or peritoneal NK cells of mice whereas the intraperitoneal injection of IL-2 preferentially activates peritoneal NK cells. The availability of human recombinant IL-2 and its capacity to stimulate mouse effector cells in vitro and in vivo will allow the preclinical assessment of the immunomodulatory and therapeutic potential of IL-2.

UR - http://www.scopus.com/inward/record.url?scp=0021613717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021613717&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0021613717

VL - 43

SP - no. 3215

JO - Federation Proceedings

JF - Federation Proceedings

SN - 0014-9446

IS - 7

ER -